magnesium sulfate has been researched along with atosiban in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Besinger, RE; Gianopoulos, JG; Mittendorf, R; Pryde, PG | 1 |
| Boubli, L; Bretelle, F; D'ercole, C; Desbriere, R; Shojai, R | 1 |
| Ingemarsson, I; Lamont, RF | 1 |
| King, JF | 1 |
| Bisits, A; Giles, W | 1 |
| Kam, KY; Lamont, RF | 1 |
| Chen, H; Du, BJ; Liu, YL; Tan, JP; Wang, YH; Zhang, JP | 1 |
| Chen, SU; Ho, HN; Lee, CN; Wu, MY; Yang, YS | 1 |
| Caldwell, DM; Haas, DM; Kirkpatrick, P; McIntosh, JJ; Welton, NJ | 1 |
| Borowiack, E; Khan, K; Kowalska, M; Meads, C; Mignini, L; Mol, B; Roos, C; Walczak, J; Zapalska, A | 1 |
| Arrowsmith, S; Neilson, J; Wray, S | 1 |
| Biro, P; Hüsler, M; Krähenmann, F; Mazzone, L; Meuli, M; Moehrlen, U; Ochsenbein-Kölble, N; Zimmermann, R | 1 |
| Coates, S; Gotteland, JP; Lorch, U; Marchand, L; Pohl, O; Täubel, J | 1 |
9 review(s) available for magnesium sulfate and atosiban
| Article | Year |
|---|---|
Adverse and beneficial effects of tocolytic therapy.
Topics: Adrenergic beta-Agonists; Calcium Channel Blockers; Cyclooxygenase Inhibitors; Female; Fetal Death; Fetal Diseases; Humans; Magnesium Sulfate; Obstetric Labor, Premature; Oxytocin; Pregnancy; Randomized Controlled Trials as Topic; Tocolytic Agents; Vasotocin | 2001 |
[Tocolysis: indications and contraindications. When to start and when to stop].
Topics: Clinical Trials as Topic; Contraindications; Female; France; Gestational Age; Humans; Indomethacin; Magnesium Sulfate; Obstetric Labor, Premature; Practice Guidelines as Topic; Pregnancy; Prognosis; Tocolysis; Tocolytic Agents; Treatment Outcome; Vasotocin | 2002 |
An update on the controversies of tocolytic therapy for the prevention of preterm birth.
Topics: Adrenergic beta-Agonists; Calcium Channel Blockers; Cyclooxygenase Inhibitors; Female; Humans; Magnesium Sulfate; Nitric Oxide Donors; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Prostaglandin-Endoperoxide Synthases; Tocolytic Agents; Vasotocin | 2003 |
Tocolysis and preterm labour.
Topics: Calcium Channel Blockers; Cyclooxygenase Inhibitors; Female; Humans; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Tocolysis; Tocolytic Agents; Vasotocin | 2004 |
Preterm labour. The present and future of tocolysis.
Topics: Adrenergic beta-Agonists; Female; Humans; Indomethacin; Magnesium Sulfate; Nifedipine; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents; Treatment Failure; Vasotocin | 2007 |
Developments in the pharmacotherapeutic management of spontaneous preterm labor.
Topics: Female; Fetus; Glucocorticoids; Health Care Costs; Humans; Magnesium Sulfate; Nifedipine; Obstetric Labor, Premature; Pregnancy; Premature Birth; Tocolytic Agents; Vasotocin | 2008 |
Use of atosiban in a twin pregnancy with extremely preterm premature rupture in the membrane of one twin: a case report and literature review.
Topics: Adult; Female; Fetal Growth Retardation; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Male; Pregnancy; Pregnancy, Multiple; Premature Birth; Reproductive Techniques, Assisted; Ritodrine; Tocolysis; Tocolytic Agents; Twins; Vasotocin | 2010 |
Tocolytic therapy for preterm delivery: systematic review and network meta-analysis.
Topics: Calcium Channel Blockers; Female; Humans; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prostaglandin Antagonists; Randomized Controlled Trials as Topic; Time Factors; Tocolysis; Tocolytic Agents; Treatment Outcome; Vasotocin | 2012 |
What do we know about tocolytic effectiveness and how do we use this information in guidelines? A comparison of evidence grading.
Topics: Adrenergic beta-Agonists; Attitude of Health Personnel; Calcium Channel Blockers; Evidence-Based Medicine; Glucocorticoids; Humans; Indomethacin; Lung; Magnesium Sulfate; Nitric Oxide Donors; Practice Guidelines as Topic; Premature Birth; Research Design; Surveys and Questionnaires; Tocolytic Agents; Vasotocin | 2013 |
2 trial(s) available for magnesium sulfate and atosiban
| Article | Year |
|---|---|
Tocolysis for in utero Surgery: Atosiban Performs Distinctly Better than Magnesium Sulfate.
Topics: Adult; Female; Fetal Therapies; Humans; Magnesium Sulfate; Pregnancy; Prospective Studies; Tocolysis; Tocolytic Agents; Vasotocin | 2018 |
Coadministration of the prostaglandin F2α receptor antagonist preterm labour drug candidate OBE022 with magnesium sulfate, atosiban, nifedipine and betamethasone.
Topics: Adolescent; Adult; Area Under Curve; Betamethasone; Cross-Over Studies; Drug Interactions; Esters; Female; Humans; Magnesium Sulfate; Middle Aged; Nifedipine; Receptors, Prostaglandin; Sulfones; Thiazolidines; Tocolytic Agents; Vasotocin; Young Adult | 2019 |
2 other study(ies) available for magnesium sulfate and atosiban
| Article | Year |
|---|---|
[Clinical experience of using oxytocin antagonist atosiban in the rescue therapy of preterm labour].
Topics: Adult; Female; Hormone Antagonists; Humans; Infant, Newborn; Injections, Intravenous; Magnesium Sulfate; Obstetric Labor, Premature; Oxytocin; Pregnancy; Pregnancy Outcome; Ritodrine; Tocolytic Agents; Treatment Outcome; Vasotocin | 2008 |
The combination tocolytic effect of magnesium sulfate and an oxytocin receptor antagonist in myometrium from singleton and twin pregnancies.
Topics: Adult; Cesarean Section; Female; Humans; In Vitro Techniques; Magnesium Sulfate; Myometrium; Pregnancy; Pregnancy, Twin; Receptors, Oxytocin; Tocolytic Agents; Uterine Contraction; Vasotocin | 2016 |